Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ropeginterferon”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Looking for participantsNCT07249840
What this trial is testing

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Who this might be right for
JAK2 Mutation
Brigham and Women's Hospital 12
Post-approval studies (Phase 4)Study completedNCT07105319
What this trial is testing

Ropeginterferon for Treatment Free Remission

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Dong-Wook Kim 65
Early research (Phase 1)Not Yet RecruitingNCT07521046
What this trial is testing

Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)

Who this might be right for
Myelofibrosis
University of Utah 15
Early research (Phase 1)Study completedNCT03546465
What this trial is testing

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics Study of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects

Who this might be right for
Healthy Volunteers
PharmaEssentia Japan K.K. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05485948
What this trial is testing

Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

Who this might be right for
Polycythemia Vera
PharmaEssentia 49
Testing effectiveness (Phase 2)Looking for participantsNCT05731245
What this trial is testing

Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis

Who this might be right for
Pre-fibrotic Myelofibrosis
National Taiwan University Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Early research (Phase 1)Study completedNCT04638439
What this trial is testing

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Who this might be right for
Chronic Hepatitis B InfectionChronic Hepatitis D Infection
PharmaEssentia 20
Testing effectiveness (Phase 2)Looking for participantsNCT06770842
What this trial is testing

Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
The University of Hong Kong 20
Large-scale testing (Phase 3)Study completedNCT04382937
What this trial is testing

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
PharmaEssentia 222
Post-approval studies (Phase 4)WithdrawnNCT06290765
What this trial is testing

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Who this might be right for
Polycythemia VeraMyeloproliferative Neoplasm
PharmaEssentia
Large-scale testing (Phase 3)UnknownNCT05808322
What this trial is testing

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities

Who this might be right for
COVID-19
National Taiwan University Hospital 60
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04285086
What this trial is testing

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Who this might be right for
Essential Thrombocythemia
PharmaEssentia 174
Testing effectiveness (Phase 2)UnknownNCT04988815
What this trial is testing

Ropeginterferon Alfa 2b for Early Myelofibrosis

Who this might be right for
Primary Myelofibrosis, Prefibrotic StageMyelofibrosis
The University of Hong Kong 50
Large-scale testing (Phase 3)Study completedNCT05770466
What this trial is testing

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.

Who this might be right for
COVID-19
National Taiwan University Hospital 134
Testing effectiveness (Phase 2)UnknownNCT05467553
What this trial is testing

Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection

Who this might be right for
Hepatitis D
National Taiwan University Hospital 30
Early research (Phase 1)Looking for participantsNCT07047885
What this trial is testing

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06468033
What this trial is testing

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Who this might be right for
Primary MyelofibrosisMyeloproliferative Neoplasm
PharmaEssentia 160
Testing effectiveness (Phase 2)Looking for participantsNCT07269470
What this trial is testing

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 40
Next Page